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Abstract
Background: Cystic poorly differentiated nephroblastoma (CPDN) is a rare variant of nephroblastoma
which follows a benign clinical course.
Case  diagnosis/treatment:  In this report, we document a case of CPDN in a 2 year old boy who pre-
sented with recurrent gross painless hematuria and progressive abdominal distension. Abdominal ultrasound
showed a multicystic lesion and CT scan features of Stage III Wilms tumour. Nephrectomy was done after
two cycles of chemotherapy according to the SIOP Nephroblastoma therapeutic protocols. Histology showed
blastemal cells in the wall of only one of the cysts, with no solid expansile nodules. The patient had to have
five more cycles of chemotherapy and also radiotherapy for residual tumour.
Conclusions:  Surgery is curative in Stage I CPDN and adjuvant therapy is not required. Adequate sampling is
critical to ensure accurate diagnosis and appropriate management. We suggest that a minimum of 2–3 tissue
sections should be taken per centimetre of tumour diameter. Related entities including cystic nephroma,
cystic Wilms tumour and completely necrotic nephroblastoma are discussed in the differential diagnosis.
© 2014 Pan African Urological Surgeons’ Association. Production and hosting by Elsevier B.V. 
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ystic poorly differentiated nephroblastoma (CPDN) is a rare vari-
nt of nephroblastoma [1]. To the best of our knowledge, this is∗ Corresponding author. Tel.: +234 8033503915.
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ttp://dx.doi.org/10.1016/j.afju.2014.04.001he first documented case of this variant of nephroblastoma from
igeria.
ystic poorly differentiated nephroblastoma is a multilocular cystic
ariant of Wilms tumour which follows a benign clinical course
1,2]. Surgery is curative in almost all patients [1–3]; and the
are cases of local recurrence are thought to be due to incomplete
esection [1,2,4]. Patients with Stage I CPDN can appropriately
e managed by nephrectomy and conservative follow-up alone,
ith no adjuvant therapy indicated [1–4]. Once tumour does not
xtend beyond the kidney, tumour does not involve the resection
d hosting by Elsevier B.V. Open access under CC BY-NC-ND license.
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Figure  1  Macroscopic picture of the kidney with a multicystic lesion at the midportion and residual kidney tissue at both poles.
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dmargins, and tumour spillage does not occur during nephrectomy,
surgery alone would be curative in a patient with CPDN [1–4].
Hence, it is pertinent that the patients presenting with CPDN are
accurately diagnosed and are not managed like high risk nephrob-
lastoma. This will ensure that patients with nephroblastoma are
spared from the administration of adjuvant therapy in all clinical
situations where it may be unnecessary and potentially harmful
[5,6].
Case diagnosis/treatment
We present a 2-year-old boy who was first seen at the Children’s
Emergency ward having been referred from a private hospital on
account of hematuria, an abdominal ultrasound which was said to
have been suggestive of the left polycystic kidney, and intravenous
urogram suggestive of the left cystic nephroma.
The patient had had hematuria on and off for 4 weeks prior to pre-
sentation. During each episode, the passage of blood was total and
painless. At presentation, he also had progressive abdominal dis-
tension of 8 days’ duration and high grade continuous fever of 5
days’ duration. There was significant background history of failure
to thrive.
On examination, he was found to have high grade fever and a left
flank mass measuring 5 by 6 cm. Full blood count showed a packed
cell volume (PCV) of 23% and differential white blood cell count
showed 60% neutrophilia, both likely due to sepsis. The eryth-
rocyte sedimentation rate (ESR) was moderately elevated. Urine
microscopy showed features suggestive of urinary tract infection.
An assessment of possible nephroblastoma with sepsis, with the
focus in the urinary tract was made. Abdominal ultrasound showed
multiple cysts with extensive areas of necrosis but no solid areas,
t
h
p
ohese features were said to be suggestive of a cystic Wilms tumour.
bdominal CT scan showed features consistent with nephroblas-
oma Stage III.
 radical nephrectomy was performed after 2 courses of chemother-
py with vincristin, actinomycin D and doxorubicin. There had been
o prior pre-chemotherapy biopsy or diagnosis. At surgery, the renal
umour was found to have infiltrated the muscles of the posterior
bdominal wall (SIOP Stage III disease).
ross examination showed a kidney weighing 150 g and measur-
ng 9 cm ×  7 cm ×  3 cm. There was infiltration of the renal capsule
y tumour with extension into the perinephric fat. There were no
nlarged lymph nodes within the perinephric fat. The adrenal gland
as not involved by the tumour.
ut sections through the left kidney showed a lesion located about
he mid-portion of the kidney with residual renal tissue at both poles;
t measured 5 cm ×  4 cm ×  2.5 cm. The lesion was totally cystic with
o solid areas identified. Some of the cysts contained chocolate-
oloured or serous fluid, others of gelatinous material and a single
yst consisted entirely of yellowish-brown necrotic material (Fig. 1).
istology showed a well circumscribed lesion consisting of multiple
ysts which did not communicate with one another or with the renal
elvis. These cysts were lined by cuboidal to columnar epithelium
hich appeared attenuated or absent in some of the cysts. Some are
ined by cells with a hobnail appearance. The cysts are separated by
elicate fibrous septa. Old and recent hemorrhage were seen within
he lumina of some of the cysts. Sheets of foamy macrophages,
emosiderin-laden macrophages admixed with lymphocytes and
lasma cells are seen within the walls of many of the cysts. One
f the cysts shows necrotic debris within its lumen. Blastemal cells
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re seen within the wall of another of the cysts. There were no asso-
iated immature stromal or epithelial elements. There were no solid
xpansile nodules. The round contour of the cyst with blastemal
ells in its wall is maintained and is not distorted by the cell clus-
ers. No areas of anaplasia are seen. There was no involvement of
he hilar vessels by tumour. The ureter appeared unremarkable.
ince surgery, the patient has had five more courses of chemother-
py and external beam radiotherapy to the tumour bed. The patient
eveloped pancytopenia after chemotherapy which was managed
ith supportive therapy consisting of transfusions with blood and
latelet concentrate. There were recurrent episodes of sepsis delay-
ng the commencement of a new cycle of chemotherapy on two
ccasions.
reatment was completed in April 2012, and the post-treatment
ourse has been uneventful.
iscussion
ystic poorly/partially differentiated nephroblastoma is a multiloc-
lar cystic variant of Wilms tumour composed entirely of cysts lined
y flattened to cuboidal epithelium and separated by delicate septa
1–4]. The septal stroma contains small foci of blastema, primitive
r immature epithelium, and/or immature appearing stromal cells,
nd this feature distinguishes CPDN from cystic nephroma [1–4].
ystic nephroma and CPDN are histologically distinct but grossly
nd radiologically identical. In other words, these entities cannot be
ifferentiated on imaging studies or on naked eye examination of the
idney [1,7,8]. Cystic nephroma is sometimes classified with cys-
ic partially differentiated nephroblastoma (CPDN) as a multilocular
ystic renal tumour [8]. In 1989, Joshi and Beckwith proposed mod-
fied terminology and refined diagnostic criteria to help differentiate
ystic nephroma from CPDN and other cystic renal tumours such
s Wilms tumour with cyst formation [7,9].
irtually all cases of CPDN are diagnosed in children younger than
4 months [1–3], and males are affected about twice as often as
emales [1,2]. The index patient, a 2-year-old boy falls within the
eak age range of occurrence for CPDN.
e presented with hematuria, a less common symptom of nephrob-
astoma than abdominal mass which is the most common presenting
eature [1,3]. A flank mass was found on clinical examination.
 clinical diagnosis of nephroblastoma had been made in this patient
ased on the clinical history, findings on clinical examination and
adiologic findings. CPDN is often diagnosed as Wilms’ tumour on
linical and radiologic grounds [3].
or pediatric tumours, a minimum of one section for each centimetre
f the diameter of the tumour is recommended during sampling for
istology [10]. This would suggest that obtaining a minimum of five
ections in the index patient, whose kidney tumour had a widest
iameter of 5 cm, should have been adequate. We initially reviewed
ight sections which were obtained from various areas of the lesion
fter bivalving and serial sectioning. None of these sections showed
ephroblastoma cells in the walls of the cysts and a diagnosis of
ystic nephroma would have been submitted with significant clinical
mplications.
i
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wM.O. Odubanjo et al.
he CT and intraoperative findings in this patient had, however,
ppropriately led the pathologist to also consider the possibility of
 CPDN or cystic Wilms tumour in this multilocular cystic lesion of
he kidney. Consequently, further sections were obtained. One of the
ix additional sections showed blastemal cells in the wall of only
ne of the cysts seen. We suggest that for multicystic tumours of
he kidney in children, the criteria for adequate sampling should be
xtended such that a minimum of two to three sections is obtained per
entimetre of the diameter of the tumour. Further studies would help
o clearly define specific adequate sampling criteria for multicystic
umours of the kidney.
idespread sampling of multiple cyst walls with special attention
o the areas where the walls are not transparent will significantly
ncrease the possibility of finding the diagnostic nephroblastoma
ells–blastemal cells, epithelial and or stromal elements.
he results of the International Society of Paediatric Oncology
SIOP) trials and studies published in 2002 highlight the important
ole that the finding of blastemal cells in nephroblastoma plays in
rescribing prognosis to patients [11]. They showed that, for treat-
ent purposes, only three major types of nephroblastoma need to be
ecognized: completely necrotic (low risk tumour), blastemal (high
isk tumour), and others (intermediate risk tumours).
his patient was managed using the SIOP therapeutic protocols
hich recommend pre-operative chemotherapy. The main advan-
age of this treatment protocol is that it significantly reduces
he likelihood of tumour spillage during nephrectomy [12]. The
ational Wilms Tumor Study (NWTS) therapeutic protocol requires
hat nephrectomy is done immediately and a diagnosis is made
efore treatment is commenced, with the advantage of ensur-
ng that chemotherapy is not administered in error to a patient
ith benign disease or a different histological type of malig-
ant tumour [12]. Overall, it has been shown that the SIOP and
WTS therapeutic protocols both yield almost equivalent clinical
utcomes [12].
uring nephrectomy, this patient was found to have Stage III dis-
ase with local infiltration of tumour into the capsule, perinephric
at and the muscles of the posterior abdominal wall. This necessi-
ated the administration of additional cycles of chemotherapy after
urgery and the application of radiation to the tumour bed. It is
nown that even though all cases of CPDN are associated with
 relatively good prognosis, adjuvant therapy has to be offered
o patients with more advanced disease than Stage I to ensure
avourable outcomes. A study of the response to treatment of
hildren with CPDN who were recruited into the NWTS showed
avourable outcomes in these patients with 100% survival rate and
o recurrences. For Stage I disease, these outcomes were achieved
ith or without chemotherapy but Stage II and more advanced
isease required addition of chemotherapy to obtain favourable
utcomes [13].
n this patient, microscopic examination showed an entirely cys-
ic lesion with blastemal cells found within the wall of one of the
ysts (Fig. 2). No immature stromal or epithelial elements were
een within the fibrous septa separating the cysts. A confound-
ng fact is whether to strictly refer to a renal tumour such as is
ound in this patient as a cystic poorly differentiated nephroblas-
oma because it consists of blastemal cells alone and a tumour
ith blastema along with more differentiated tissue including
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Figure  2  A photomicrograph showing a cyst with blastemal cells
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nephroblastoma. Journal of Urology 2010;(183) April:1585–6.within its wall (x40).
epithelial and mesenchymal elements as a cystic partially dif-
ferentiated nephroblastoma. Notably, Joshi showed that available
data do not suggest any difference in clinical behavior between
the two [3]. Moreover, there is a suggestion that there might be
two subtypes of cystic partially differentiated nephroblastoma-one
with predominantly well-differentiated elements and the other with
predominantly poorly differentiated elements-but no definite con-
clusions can be drawn regarding the existence of such subtypes on
the basis of available data [9].
Hemorrhage and necrosis were found in this patient’s renal
tumour. In Wilms tumour, extensive necrosis is known to occur
following chemotherapy. When no viable tumour is left after pre-
nephrectomy chemotherapy, the diagnosis of a completely necrotic
nephroblastoma is most appropriate. This is defined as a unilateral
non-anaplastic nephroblastoma showing total necrosis and no viable
tumour following preoperative chemotherapy [6]. This is a low risk
variant of nephroblastoma. In the index patient, abdominal ultra-
sound had shown a multicystic renal lesion with extensive necrosis
and no solid areas even before chemotherapy was commenced, on
the day after presentation to LUTH.
Other post-chemotherapy changes that are known to occur in a
nephroblastoma include xanthomatous histiocytic foci, hemosiderin
deposits and fibrosis. Chemotherapy may also induce changes such
as maturation of blastema, epithelial, and stromal components, with
striated muscle being the most frequent component seen [14].
Hemorrhage and necrosis are both known to be uncommon in mul-
tilocular cystic renal tumours [3,7,9], but focal hemorrhage and
necrosis may occur following herniation of the tumour into the
renal pelvis or ureter, which damages the thin layer of transitional
epithelium [7].
Cystic degeneration is known to occur in Wilms tumour following
hemorrhage and necrosis into the tumour with loss of tissue [8].
Wilms’ tumour with multifocal cystic change has to be distin-
guished from CPDN [1,9]. The diagnosis of a cystic Wilms tumour
is rendered when solid expansile nodules are identified even in the
presence of extensive areas of cystic degeneration in a nephroblas-
toma [1].147
he report of the International Society of Paediatric Oncology
SIOP) nephroblastoma trial and study 9, published in 2000 [6]
bserved that the high cure rates achieved for nephroblastoma in
he SIOP Nephroblastoma Trials and Studies has led to increased
ttention to the identification of low risk variants of nephroblastoma
nd of patients who could benefit from less aggressive postoperative
herapy. Even from the outset, the identification of low-risk groups
as been one of the aims of the SIOP Nephroblastoma Trials and
tudies [6].
n Nigeria, such high cure rates have not yet been achieved in
ephroblastoma seen in many of the tertiary hospitals [15,16] but a
ocus on variants of nephroblastoma requiring less aggressive ther-
py is just as useful to save our mostly indigent patients the costs
f chemotherapy and radiotherapy when such treatment modalities
ffer no additional advantage, and to avoid the morbidity and the
ate effects of adjuvant therapy.
hallenges preventing a huge success in the management of
ephroblastoma in Nigeria include late presentation with advanced
isease, reduced health awareness and poverty [15–17]. These fac-
ors make it difficult for high cure rates to be achieved.
 more recent article [18] described similar challenges in the man-
gement of malignant solid tumours in sub-Saharan Africa. These
nclude resource deficiencies that range from inadequate healthcare
udgets and a paucity of appropriately trained personnel, to scarce
aboratory facilities and inconsistent drug supplies [18]. Patients
ace difficulties accessing healthcare, they often cannot afford to
ay for investigations and or treatment protocols, or to attend rou-
ine clinic follow-up visits [18]. Children routinely present with
dvanced local and metastatic disease hence many children cannot
e offered any effective treatment [18]. In addition, multiple co-
orbidities, including malaria, tuberculosis and HIV, when added to
cute on chronic malnutrition, tend to compound treatment-related
oxicities [18]. The index patient had a history of failure to thrive
nd he presented with sepsis as co-morbidity. During chemother-
py, he had a recurrence of sepsis on two occasions which delayed
he next cycle of treatment by at least one week on each occasion.
verall, survival rates of patients with nephroblastoma in Africa are
oor [18].
n conclusion, we have been able to illustrate that CPDN ought to be
onsidered in children less than 5 years with a clinical diagnosis of
ephroblastoma, and a multicystic lesion on imaging studies and on
ross examination of the kidney. There is need for increased aware-
ess about this entity among pathologists, paediatric surgeons and
aediatricians to ensure that an accurate diagnosis can be rendered
nd the patient is appropriately managed.
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